Exhibiting at VIV Asia 2025

MPA Veterinary Medicines and Additives, headquartered in Barberà del Vallès, Spain, is a leading European manufacturer and exporter of high-performance veterinary feed additives, oral solutions, and technological tools designed to enhance animal health and productivity. With a science-driven approach and deep sector expertise, MPA serves the livestock and poultry industries through innovative, sustainable, and precision-targeted nutritional and medicinal solutions.

Core Business

MPA specializes in the research, development, and production of veterinary feed additives, functional water-soluble products, and oral veterinary medications. The company operates with a clear mission: to provide cutting-edge tools that support health, immunity, and performance in modern animal production systems while promoting responsible use of antibiotics and maximizing profitability.

Product and Service Offerings

MPA’s diverse product portfolio is categorized into the following lines:

• Technological Tools

  • FungiActive: A mycotoxin deactivator and gut protection agent combining enzymatic and absorbent actions.
  • Tensoactive: A surfactant-based biofilm-removal solution designed to optimize the efficacy of water-soluble additives and disinfectants.

• ActiveFeed Range

  • Afex Active: Designed to support intestinal health and digestive efficiency in swine and poultry.
  • Rumex Active: Tailored for ruminants, enhancing rumen function and feed conversion.

• ActiveWater Range

  • Afex Active Aqua: A water-soluble version of Afex Active, formulated for quick uptake during critical production phases.
  • Rumex Active Aqua: Specifically formulated for easy delivery via drinking water in ruminant systems.

• Oral Administration Solutions

  • Fenoxipen V: A broad-spectrum antibiotic oral solution containing phenoxymethylpenicillin, targeting respiratory and enteric bacterial infections.

These products are supported by robust clinical trials, university collaborations, and real-farm applications across multiple continents.

Specialisation and Core USP

MPA’s specialization lies in its multi-modal approach to animal health and nutrition, integrating pharmaceutical precision with advanced nutrition. Core unique selling points include:

• Synergistic product design, combining prebiotics, phytogenics, and chelated trace minerals
• Water-soluble and feed-integrated solutions for flexible administration routes
• Strong focus on mycotoxin management, biofilm control, and gut integrity
• Formulas backed by data from field trials conducted in over 20 countries

Their R&D unit actively collaborates with European universities and independent laboratories to validate efficacy, stability, and economic return.

Financial Strength and Global Reach

MPA Veterinary operates as a private company with consistent year-over-year growth supported by international expansion. As of 2023:

• Active in over 40 countries across Europe, Latin America, Asia, and Africa
• Export markets account for over 85% of annual revenue
• Partnered with more than 60 distributors worldwide
• Projected annual turnover exceeds €15 million, growing at 10–12% CAGR

The company maintains a strong presence in Spain, Latin America (notably Mexico, Colombia, and Peru), and Southeast Asia.

Shipment and Trade Data

According to data sourced from Volza and Trademo:

• Completed over 500 international shipments between 2019 and 2023
• Top exported products include Fenoxipen V, FungiActive, and Afex Active Aqua
• Average shipment value ranges between €10,000 and €40,000
• Major export destinations: Mexico, Vietnam, Egypt, Indonesia, and Nigeria

MPA’s logistics team ensures fast documentation, cold-chain shipping where required, and regulatory support for global registrations.

Target Market

MPA’s products are developed for a wide range of animal production systems, including:

• Swine and poultry integrators
• Ruminant feedlots and dairy cooperatives
• Veterinary pharmaceutical distributors
• Animal nutrition companies and premix manufacturers
• Farms with high-performance, antibiotic-free production systems

The company also supports technical advisors and veterinarians in integrating its solutions into disease prevention and nutritional management protocols.

Capabilities

• GMP+ and FAMI-QS certified manufacturing plant in Spain
• Custom formulation and co-development services for regional partners
• Microencapsulation, granulation, and liquid blending technologies
• Stability testing, residue analysis, and efficacy trials
• Regulatory dossier support for over 30 global markets
• Field application support and product training via technical teams

MPA also invests in digital tools for farm analytics and decision-making on nutritional interventions.

Certifications and Compliance

MPA operates under strict quality and regulatory frameworks:

• GMP+ (Good Manufacturing Practices for Feed)
• FAMI-QS (Feed Additives and Premixtures Quality System)
• EU Regulation 1831/2003 compliance for feed additives
• Veterinary product registration in more than 25 countries
• Compliance with Spanish Agency of Medicines and Medical Devices (AEMPS) for veterinary drugs

The company implements full traceability and recall protocols, ensuring safety and quality from production to farm.

Customer Testimonials

A livestock integrator in Southeast Asia reported:

“FungiActive not only reduced mycotoxin impact but also improved feed intake and FCR in broilers by 6%. The return on investment was clear within 3 weeks.”

A veterinary distributor in North Africa shared:

“MPA’s water-soluble additives like Afex Active Aqua are highly effective during heat stress. Our customers appreciate their performance and ease of application.”

Major Achievements

• Developed 20+ registered products across oral and feed additive categories
• Recognized by the Spanish Ministry of Agriculture as a key exporter of veterinary products
• Exhibited at global trade shows including EuroTier, VIV Europe, and VIV MEA
• Completed collaborative mycotoxin management trials with top Spanish poultry farms
• Launched new-generation phytogenic additives in 2023 with multi-strain bioactive blends

MPA Veterinary Medicines and Additives continues to lead with a science-backed, market-responsive product strategy that supports both animal health and producer profitability in an increasingly regulated global livestock industry.